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ABSTRACT 
 
 
 Nucleotide excision repair (NER) is the process by which cells identify and 
repair bulky, helix-distorting DNA lesions such as ultraviolet (UV) radiation-
induced cyclobutane pyrimidine dimers (CPD) and 6-4 photoproducts (6-4PP).   
NER in human cells is a complex biochemical process requiring several 
complementation groups.  Defects in complementation group genes result in 
rare, autosomal recessive cancer syndromes such as xeroderma pigmentosum 
(XP), cockayne syndrome (CS), and trichothiodystrophy, supporting the tumor 
suppressive effects of NER.  Protein Kinase C delta (PKCδ) expression is lost in 
squamous cell carcinomas where it functions as a tumor suppressor gene.  
Additionally, in response to UV radiation, PKCδ is known to function in the 
maintenance of the G2/M cell cycle checkpoint and apoptosis. Because cell cycle 
checkpoints are coupled to DNA damage repair pathways, this thesis 
investigates the role PKCδ plays in DNA damage repair of UV-induced adducts. 
To examine the role of PKCδ in the repair of DNA damage CPD’s, wild 
type mouse embryonic fibroblasts (MEFs) were exposed to a non-apoptotic UV 
dose (5 mJ/cm2), allowed time for repair, and then fluorescently stained for 
CPDs.  Through quantitative immunofluorescence microscopy, we found wild 
type MEFs were competent at repairing CPD’s whereas PKCδ null MEFs had 
significantly (p<0.001) reduced capacity for repair of UV-induced CPD adducts.  
 xi 
 
These results were also supported using southwestern blotting for CPDs in DNA 
isolated from wild type and PKCδ null cells exposed to high dose UV radiation.   
We also found that re-expressing PKCδ in PKCδ-/- cells restores DNA 
damage repair of CPDs. Cells infected with PKCδ expressing vector obtained 
levels of CPD repair consistent with WT cells. 
Immunofluorescene staining was also used to show decreased levels of 
nuclear xeroderma pigmentosum complementation groups A and C (XPA; XPC) 
protein in PKCδ-/- MEFs.  This data was also supported by western blot data 
which showed low endogenous levels and delayed induction of XPA and XPC in 
PKCδ-/- cells after UV irradiation.  Thus, our results indicate a role for PKCδ in 
DNA damage repair of CPDs through NER signaling.  
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CHAPTER ONE 
 
INTRODUCTION 
 
The Human Skin 
 
Anatomy of the Skin 
 
The human skin comprises the largest multifunctional organ of the body 
and accounts for roughly 15% of total body weight in adults.  The epidermal and 
dermal layers constitute the two primary layers of the skin with a subcutaneous 
layer of loose connective and adipose tissue below the inner dermal layer1,2. The 
major action of the skin is to provide protective, thermoregulatory, metabolic, and 
immunologic functions.   
The fine structure of the skin shows considerable variations in thickness, 
vascularization, innervation, and cellular distribution.  The epidermis is the 
outermost layer of the skin and continuously self-renews.  The major cell type 
found in the epidermal layer is the keratinocyte which undergoes a differentiation 
process resulting in production of flattened, anucleate cells.  Additionally, the 
epidermis also contains non-keratinocytes including  immune cells called 
Langerhans cells, melanin (pigment) producing melanocytes, and pressure 
sensitive Merkel cells3.  The epidermis can be further broken down into several 
layers, the innermost basal layer, the stratum spinosum, the granular layer, and 
the most superficial cornified layer.  Keratinocytes originate from mitotic divisions 
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of undifferentiated stem cells in the basal layer4,5.  These cell migrate upward 
toward the skin surface undergoing keratinization before shedding1,6.   
The dermis is a compressible, supportive connective tissue located below 
the epidermal layer.  This thick, relatively acellular layer is comprised of several 
cells (fibroblasts and mast cells), blood vessels, nerve endings, hair follicles, and 
sebaceous glands7.  Separating the dermis and epidermal layer is a complex 
basement membrane synthesized by keratinocytes and dermal fibroblasts. This 
membrane plays a fundamental role in mechanical support and keratinocyte 
migration during wound healing. Additionally, it is also traversed by lymphocytes 
during immunologic and inflammatory processes8.  The basement membrane is 
composed mainly of laminins and type IV and VII collagens9.  Advanced, 
neoplastic cancers grow through this barrier by releasing matrix-
metalloproteases which allow transformed epidermal cells to invade the dermis 
and enter blood vessels and metastasize to other areas of the body10. 
 
Skin Cancer 
Cancers of the skin (including melanoma and non-melanoma skin cancer) 
are the most common form of cancer with greater than one million cases 
diagnosed each year11.  The primary factor contributing to the induction of skin 
cancer is unprotected skin exposure to ultraviolet (UV) radiation from either 
environmental (sun) or industrial, man-made (tanning beds) sources12-14 .    
As previously noted, skin cancers are classified into melanoma and non-
melanoma types.  Non-melanoma skin cancers are further subdivided into 
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squamous (SCC) and basal cell carcinoma (BCC) subtypes.  BCCs are the most 
common subtype of skin cancer.  These cancers originate from transformation of 
epidermal keratinocytes and rarely metastasize15.  The second most common 
subtype, SCCs, are derived from keratinocytes that express squamous 
differentiation markers and also rarely metastasize. However SCCs are more 
metastatic than BCCs.  The non-melanoma skin cancers occur most frequently 
on UV exposed areas of the body including the face, back, shoulders, and 
scalp16.  Despite the large incidence of non-melanoma skin cancers, in most 
cases they can be cured with minor surgery or local treatments such as topical 
chemotherapies, cryosurgery, and photodynamic therapy.   
Melanoma is the least common type of skin cancer accounting for only 
~5%, but is the most metastatic and causes the majority of skin cancer deaths.  
Melanoma begins in the melanin producing cells of the skin, the melanocytes.  
Development of melanoma can occur almost anywhere on the body but occurs 
most frequently on sun exposed regions such as the chest and back of males 
and on the legs of females17. Therefore, UV is regarded as a major contributor to 
the development of both melanoma and non-melanomas skin cancers alike.        
 
Ultraviolet Radiation 
 
Exposure to UV light can, at times, lead to DNA lesions that, if not 
repaired correctly, threaten both cell and organism viability.  In skin cancers, the 
main etiological factor responsible for DNA lesions is environmental UV light.  
The most damaging wavelengths of UV radiation, UVC, are absorbed by the 
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ozone layer and are therefore physiologically irrelevant.  Therefore, cells need 
only to contend with UVA and UVB rays (315-400nm and 280-315nm 
respectively)14.   
 
UVA Radiation 
 
Roughly 95% of the UV radiation reaching the Earth’s surface is 
comprised of the wavelengths corresponding to UVA rays.  UVA rays are linked 
to long term damage to skin such as wrinkles, photoaging, and skin cancer 18,19.  
This is largely attributed to chronic exposure of UVA rays that penetrate deeply 
into the dermis. Chronic exposure to UVA has been shown to generate reactive 
oxygen species that promote carcinogenesis by damaging DNA20-22. However, 
UVA does not exist in nature without UVB and, environmentally, UVA has been 
shown to be inhibitory to UVB-induced apoptosis23. With regard to 
photocarcinogenesis, apoptosis is a protective mechanism because of its 
function as an antimutagenic and anticarcinogenic cellular response.  Therefore, 
the presence of UVA along with DNA damaging UVB will increase mutation 
burden and, similarly, skin cancer induction.   
 
UVB Radiation 
 
Despite UVA’s ability to augment UVB-mediated mutation and skin cancer 
formation, UVB is still the more directly carcinogenic of the two rays.  UVB 
primarily causes damage to the cells of the epidermis with prolonged exposure 
often resulting in sunburn and reddening.  The damage induced by UVB is 
universal affecting various biological macromolecules such as lipids, proteins, 
 5 
 
 
and nucleic acids 24,25. However, the UV-induced mutations that give rise to skin 
cancers are derived from the modifications to DNA.  Of particular concern for 
genome stability are bulky, helix-distorting dimeric pyrimidine photoproducts 
including cis-syn cyclobutane pyrimidine dimers (CPDs), 6-4 photoproducts (6-
4PPs), and Dewar’s valence isomers26,27. Sites of adjacent pyrimidine bases 
within a DNA strand are often the preferred sites of UV-induced photolesion 
formation28.  While most damage will be CPDs, UV radiation can induce a wide 
range of damage including protein-DNA crosslinks, oxidative base damage (e.g. 
8-oxo-7,8-dihydroxyguanine), and single strand breaks 28. However, of these 
DNA adducts, CPDs are more difficult for cells to repair and are therefore the 
most carcinogenic lesion29.    
 
UV-Induced Photolesions 
 
CPDs constitute the predominate form of UV-induced photodamage.  
They are formed from a [2+2] cycloaddition between the C5-C6 double bonds of 
adjacent pyrimidine nucleotides30. The majority of CPDs occur between adjacent 
thymines but can theoretically be derived from any combination of pyrimidines as 
a direct result of the wavelengths, dose of irradiation, and adjacent nucleotide 
sequences30,31.  
6-4PPs are the second most prevalent form of induced photolesion. Like 
CPDs, 6-4PPs preferentially form between TT, CT, and CC nucleotides with an 
induction yield depending on wavelengths and adjacent nucleotide 
sequences27,32.  Upon further irradiation with UVB, 6-4PPs can further rearrange 
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to form Dewar’s valence isomers however the biological significance of this 
conformation change is unknown33. 
Despite being formed in a similar fashion, structural and biological 
differences exist between CPDs and 6-4PPs. Structurally, CPDs result in little 
strain in Watson-Crick base pairing whereas 6-4PPs result in a pronounced 
alteration that results in a loss of pairing. The amount of induced DNA burden 
accounts for differences in rate and efficiency of cellular processing of the 
photolesions.  Because 6-4PPs cause a greater amount of strain DNA repair 
proteins can identify and excise these lesions more rapidly and with greater 
accuracy than CPDs34.             
CPDs are produced both by UVB and UVA radiation35. Because UVA is 
not directly absorbed by DNA, the formation of CPDs occurs through a 
mechanism differing from the direct excitation pathway observed in UVB induced 
CPDs.  This theory was derived from studies performed in bacteria in which 
bacteria exposed to UVA preferentially induced CPDs at adjacent thymine sites 
without any detectable formation of 6-4PPs36-38.  Additionally, the rate of removal 
of CPDs generated by UVA rays is lower than those produced by UVB irradiation 
in skin35. However, whether these bulky photolesions are derived from UVA or 
UVB, CPDs and 6-4PPs are repaired through the nucleotide excision repair 
mechanism. 
 
DNA Damage Response 
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Proper regulation of cellular propagation is dependent on the cell’s ability 
to maintain stable genetic material over many cell generations.  However, various 
endogenous and exogenous agents cause DNA damage that constantly 
challenges genomic integrity. In order to combat both irradiation and chemically 
induced aberrations, the cell employs molecular mechanisms that repair 
damaged DNA and thus prevent tumorogenesis.  These mechanisms include 
base-excision repair (BER), which excises damaged or inappropriately matched 
bases as single nucleotides, and nucleotide excision repair (NER), which is 
primarily concerned with the removal of bulky, helix distorting adducts such as 
CPDs and 6-4PPs39,40.   
 
Nucleotide Excision Repair 
 
NER recognizes and repairs helix-distorting base lesions. This includes 
UV photolesions such as CPD, 6-4PPs, as well as polycyclic aromatic 
hydrocarbon adducts. This highly sophisticated process can be separated into 
two sub-pathways, discernable by the location and recognition of the lesion.  
Global-Genomic NER (GG-NER) repairs lesions over the entire non-transcribed 
regions of the genome, while repair of lesions that block transcription on template 
DNA strands is considered Transcription-Coupled NER (TC-NER). NER in 
human cells is a complex biochemical process requiring several proteins.  The 
ability of NER machinery to discriminate damaged from undamaged DNA is 
contingent on several subunits of the NER multi-protein machine.   
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At sites of base damage, a multi-protein complex assembles in a step-
wise fashion to excise the damaged oligonucleotide sequence. Studies of this 
complex have identified XPC, XPA, and RPA as the critical proteins for 
recognition of sites of damage. However, several additional proteins have proved 
vital for recruitment of other NER proteins and excision of damaged DNA 
regions33,41,42. 
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Figure 1: Essential Features of Nucleotide Excision Repair 
Nucleotide excision repair (NER) operates on base damage caused by 
exogenous agents that cause alterations in Watson-Crick base pairing leading to 
bulky lesions in the DNA duplex. A. In Global Genomic NER (GG-NER) the 
lesion is recognized by heterodimer complex XPC-hHR23B.  Initial recognition 
leads to recruitment of a pre-incision complex including TFIIH, XPA, XPD, XPB, 
XPG, and RPA. This complex binds the lesion, unwinds the DNA, and recruits 
endonuclease XPF-ERCC1. After assembly, the complex cleaves and excises 
the damaged region of DNA.  The excised region is replaced by a post-excision 
proteins Pol δ/ε, PCNA, RPA, RFC, and DNA ligase.  B. Trancription coupled 
NER (TC-NER) differs in lesion identification. Instead of XPC-hHR23B, the lesion 
is identified by Pol III, CSA, and CSB. Despite this difference, subsequent 
proteins and processes are identical to GG-NER.        
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XPC, a 125-kD protein, is exclusive to GG-NER and is essential for initial 
recognition and binding of the site of DNA damage42.  Two observations 
characterized XPC as the first protein to bind DNA damage in the process of 
NER.  First, cells deficient in XPC are only deficient in the process of GG-NER 
and not TC-NER which indicates an early role in NER signaling.  Additionally, 
irradiating cells through a porous polycarbonate filter caused localized UV-
induced damage which allowed colocalization studies of NER proteins with CPD 
damage43-45.  These studies observed that XPC colocalized with sites of damage 
in XPA deficient cells, while XPA could not be recruited in XPC deficient cells44. 
Therefore these findings also established the presence of XPC as a necessity for 
the recruitment of XPA to the site of damage44.  In vitro studies of purified XPC 
have shown that it alone is sufficient to bind damaged DNA regions.  However, 
XPC typically exists as a heterodimer that is tightly complexed to hHR23B. 
Binding to hHR23B improves XPC stability and efficiency of binding to DNA 
damage46.  A second protein, hHR23A, with similar homology to hHR23B, can 
also bind with XPC, but does not increase XPC efficiency for damage 
identification as well as hHR23B39.   
Transcription factor IIH (TFIIH) is a ten subunit subcomplex, essential for 
GG-NER and TC-NER, and is typically associated with initiation of RNA 
polymerase II transcription. However this subcomplex is also recruited to DNA 
adduct sites during UV-induced DNA damage47,48. Central to the overall function 
of this subcomplex are proteins XPB and XPD which exhibit DNA-dependent 
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ATPase and helicase functions49.  The unwinding associated with TFIIH 
generates junctions between double-stranded DNA that are fundamental for 
correct excision of damaged DNA39,50,51.  This critical process occurs in two, well 
defined, steps. Firstly, TFIIH is recruited through protein-protein interaction with 
XPC-hHR23B to the site of damage.  This step is ATP-independent. In an 
second ATP-dependent step, XPB and XPD unwinds DNA providing space for 
subsequent NER proteins52,53. 
XPA, a metalloprotein containing a DNA binding Zn2+ finger, is another 
NER protein essential for recognition of DNA damage.  XPA is crucial for the 
early stages of both GG-NER and TC-NER.  It’s ability to recognize damaged 
regions is contingent on two fundamental occurrences: disruption of normal 
Watson-Crick base pairing and altered structural chemistry of bases of the 
damaged strand54,55. XPA is recruited to the site of damage through a physical 
interaction with checkpoint ataxia-telangiectasia mutated and RAD3-related 
(ATR) kinase which translocates the protein from the cytosol into the nucleus56. 
Additionally, XPA maintains crucial contacts with other core repair factors 
including RPA.  It is suggested that the specificity of RPA is contingent on 
interactions with XPA that provide great specificity in regards to strand position57. 
RPA is a single-stranded DNA binding protein composed of three subunits 
of 70, 32, and 14 kD each with DNA binding domains58,59. RPA displays two 
inherent binding patterns, one spanning 8-10 nucleotides and another roughly 
~30.  The latter of which occludes the undamaged single-strand DNA formed by 
the TFIIH subcomplex 60-62.          
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Two additional NER proteins recruited to the site of damage are the 
endonucleases XPG and XPF-ERCC1.  XPG is an endonuclease specific for 3’ 
end incision63.  Beyond its role as an endonuclease, XPG has also been shown 
to stabilize the preincision protein complex through binding to RPA.  XPG is also 
required for the 5’ incision by XPF-ERCC1 heterodimer by stabilizing the double 
strand bubble created by the helicases of TFIIH64,65.  XPF-ERCC1 are the last 
proteins to join the complex before excision of the damaged region. This 
heterodimer is recruited to the site of damage by XPA and is the major protein 
responsible for the transition between the incision making protein complex and 
the repair synthesis66-69. 
The repair and ligation steps in NER take place in the same fashion as 
that of replication. This process requires polymerase processivity factor PCNA, 
PCNA-dependent DNA polymerase δ or ε, RPA, pentameric clamp loader RFC, 
and DNA ligase I58,70-73. This mechanism is well defined and serves to reestablish 
intact double-stranded DNA. 
 
Gene Regulation of NER Proteins 
 
 The effectiveness of NER is contingent on the proteins that comprise the 
process. Therefore, repair of damage is dependent on regulation of the genes 
encoding the NER proteins.  The mechanism that governs NER protein 
regulation is not completely understood, however p53 and low-dose UVB have 
been shown to act in this photoprotective response.  NER genes are induced in 
keratinocytes exposed to low levels of UVB, whereas exposure at high doses of 
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UVB downregulates NER genes and is associated with preparation for cell 
death74. These results were found to be true of nearly all NER genes. This 
observation has led to the belief that there exists a common regulatory pathway 
for all genes in the NER pathway.   
 
NER Deficiency Syndromes 
 
The phenotypic consequences of a defect in one of the NER proteins are 
illustrated by the occurrence of rare autosomal recessive disorders: xeroderma 
pigmentosum (XP), cockayne syndrome (CS), and trichothiodystrophy (TTD).  
Several complementation groups have been identified that contribute to the NER-
defective class of XP patients (XPA through XPG), two in CS patients (CSA and 
CSB), and three associated with TTD (XPB, XPD, and TTDA)75.  Cells from these 
individuals share an impaired capacity to repair UV induced DNA photolesions 
located either in the transcribed regions of DNA or within inactive regions of the 
genome. 
XP patients carry cutaneous hallmarks including red, blotchy parchment 
skin and freckles and are characterized by a severe predisposition for the 
development of skin cancers on UV exposed regions of the body such as the 
face, head, neck, and arms.  Due to the defective nature of their NER machinery, 
UV radiation from sun exposure generally leads to degenerative alterations of the 
skin and eyes.   XP patients develop melanoma at normal rates but frequently 
develop squamous cell and basal cell carcinomas39.  Due to their molecular 
phenotype, the UV exposed cells experience increased mutational burden and 
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readily undergo neoplastic transformation 32.  Severity of repair deficiency and 
symptoms experienced vary depending on which of the several XP proteins are 
truncated by mutation or deleted.  XPA, XPB, XPD, and XPG patients suffer a 
severe deficiency in NER repair of genomic damage.  However, XPD and XPG 
maintain low residual activity that can be >50%  repair synthesis levels in some 
cases76.  Additionally, patients with an absence of GG-NER specific protein, 
XPC, experience wild-type sensitivity to sunburn because transcription-coupled 
photolesions are removed normally.  Typically, XPC deficient  cells have residual 
repair levels of roughly 15-30% and are less sensitive to UV than patients 
deficient in XPA77-79. 
CS is caused by a mutational inactivation of genes encoding TC-NER 
proteins CSA and CSB.  This inactivation results in increased sensitivity to UV 
and other DNA damaging agents.   CS is a very pleotropic disease causing not 
only photosensitivity, but also physical and mental retardation.  However, despite 
increased photosensitivity these patients shockingly do not exhibit a 
predisposition for developing skin cancer 76,80. Physical anomalies including 
skeletal deformation (curving of the spine), microcephaly, and osteoporosis have 
been observed.  Furthermore, neurological irregularities such as progressive 
neurological degeneration, myelination abnormalities, retinopathy, and 
sensorineural hearing loss are frequently observed 80.            
The development of CS has unveiled many difficulties with regard to 
explaining the observed phenotypes through NER insufficiency alone.  It has 
been shown that CSB knockout mice experience reduced symptoms of CS while 
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CSB/XPA double mutant mice fail to grow and die before weaning 81.  
Additionally, CS cells have increased difficulty repairing ionizing radiation 
inducing oxidative damage to the transcribed DNA 80,82.  XPG deficient patients 
experience some symptoms similar to CS patients, yet impaired transcription-
coupled repair of oxidative damage is unique to cells from CS patients 83. 
Nevertheless, the additional neurological and developmental symptoms observed 
in CS suggest that transcription coupled repair proteins CSA and CSB may have 
functions beyond those observed in NER. 
 Individuals with TTD suffer from several mental and physical conditions 
including mental retardation, failure to thrive, ichthyotic skin, and brittle hair and 
nails 39,84. Several syndromes fall into the category of TTD including Pollitt 
syndomre, Tay’s syndrome, Amish brittle hair syndrome, and Sabinas 
syndrome75.  Most cases of TTD present with photosensitivity, but this is not true 
of all reported TTD patients. NER deficiency in TTD afflicted individuals was 
described through discovery of a mutation in XPD that revealed severe physical 
symptoms atypical of XP alone 85. 
 DNA polymerases synthesize DNA.  However, they also play a role in 
DNA damage tolerance and carcinogenesis. Tolerance occurs when specialized 
polymerases, such as DNA polymerase δ and ε, place a base-pair opposite DNA 
damage adducts and bypass the damage. This process is known as translesion 
DNA synthesis (TLS) and is responsible for many point mutations in the cell86. 
However, in the absence of these error-generating DNA polymerases, no 
translesion bypass will occur which results in replication fork collapse, leading to 
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double strand breaks and genome instability, which increases the incidence of 
cancer87,88. 
Structure and Regulation of Protein Kinase C 
Protein kinase C (PKC) comprises a family of 9 serine/threonine kinases 
with distinct and sometimes opposing roles in transducing signals associated 
with cell proliferation, differentiation, apoptosis, and angiogensis89,90.   
The structure of the PKC molecules consists of two major domains, a 
regulatory and catalytic at the amino and carboxy terminal ends respectively. 
Both domains consist of highly conserved regions (C1-C4) and regions of great 
variability (V0-V5) (Figure 2).  The C1 and C2 regions are important in PKC 
activation and are found in the regulatory domain91. The C3 and C4 are located 
in the catalytic fragment and are the ATP-binding and kinase regions 
respectively92.    
PKCs exist in an inactive conformation due to binding of the regulatory 
domain to the catalytic domain through an inhibitory pseudosubstrate 
sequence93. The PKC family is divided into three groups differing in their cofactor 
requirements for activation.  These groups include the conventional PKC 
isoforms (α, β, and γ) that are activated by Ca2+ and diacylglycerol (DAG); novel 
PKC isozymes (δ, ε, ε, and ζ) that require only DAG for activation; and atypical 
(δ, and λ/η) that require neither Ca2+ nor DAG but can be stimulated by agents 
such as phosphatidylserine94.  DAG is produced by the cleavage of 
phosphoinositol bisphosphate cleavage by phospholipase C 95.  Cofactor binding 
causes release of inhibition by pseudosubstrate and an increase in PKCs affinity 
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for cell membranes92. Additionally, PKCs are activated by proteolytic cleavage in 
the hinge region, which, in turn, releases the active catalytic fragment from the 
pseudosubstrate domain96,97. 
 
  
 
 
Figure 2: Protein Kinase C Isozyme Structure and Classification 
The general structure of PKC has 4 conserved domains (C1-C4): C1 contains 
motifs that form the DAG and phorbol ester binding sites. C2 contains calcium 
and acidic lipid recognition sites. C3 and C4 form the ATP and subtrate binding 
lobes of the catalytic site.  Deviations from general structure include the C2 
domain of novel PKCS which lacks amino acids to bind calcium and atypical 
PKCs which lack structure to bind DAG and calcium.  
 
 
Along with the variations in structure and activation, PKC isozymes also 
differ in biological function, tissue distribution, subcellular localization, and 
substrate specificity. Generally, PKC isozymes reside in the cytosol of the cell 
and, upon activation, translocate to the cell membrane or a cellular organelle98. 
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Cell specific isozyme functions are relative to their subcellular localization.  
Furthermore, compartmentalization contributes to discrepancies in 
activation99,100. These discrepancies in activation, subcellular localization, and 
compartmentalization raise the possibility of developing therapeutics that target 
specific PKC isozymes in tumor cells.  
 
PKCs and Cancer 
 
 The function of PKCs in cancer is complex.  Increased and decreased 
PKC levels have been associated with malignant transformation in cell lines 
associated with breast, lung, skin, gastric carcinomas, and many other 
cancers101,102.  However, deviations from normal levels that give rise to cancers 
are dependent on the primary functions of specific PKC isozymes.  For instance, 
PKCβ has been implicated in cellular proliferation and differentiation.  In the early 
stages of colon cancer, the expression of the PKCβII splice variant increases 
significantly via the cyclooxygenase 2 (COX2) and transforming growth factor β 
(TGFβ) pathways103,104.  Likewise, PKC activation and inhibition has been 
correlated with induction of apoptosis.  Several PKCs including α and ε are 
phosphorylated by the PI3K pathway and, upon activation, phosphorolate AKT105-
107. Furthermore, PKCα phosphorylates anti-apoptotic protein BCL2 signaling cell 
survival108. However,the PKCδ isozyme, is a the major isozyme responsible for 
pro-apoptotic tumor suppression109,110.   
 
Protein Kinase C δ Structure and Function 
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Protein kinase C Delta (PKCδ) is a calcium independent (novel) PKC 
isozyme activated by DAG and phorbol esters such as 12-O-
tetradecanoylphorbol-13-acetate (TPA)111,112. In humans, PKCδ is ubiquitously 
expressed and has several known functions in cell cycle regulation and 
apoptosis.  The structure of PKCδ is analogous to all novel PKCs with the 
exception of the C4 region of the catalytic domain.  In PKCδ, the C4 domain 
contains a nuclear localization sequence that is essential for PKCδs role in 
apoptosis113,114,115. Typically, PKCδ is regulated by tyrosine phosphorylation 
within the hinge region or regulatory domain at Tyr 52, 187, 311, 512 and 523 
residues116-118.  Tyrosine phosphorylation is usually associated with inhibition of 
PKCδ, but has been shown in some cases (Tyr 311) to promote functional 
activation when cells are stimulated with substances such as phorbol esters, 
hormones, and growth factors119-122. In response to several pro-apoptotic stimuli 
such as ionizing radiation, reactive oxygen species (ROS), ultraviolet radiation, 
growth factors, and cytokines, PKCδ is activated through proteolytic cleavage by 
caspase-3 to a 40-kDa catalytic fragment (Figure 3).  Once activated PKCδ 
translocates from the cytoplasm to the nucleus or to the mitochondria93. Activated 
PKCδ phosphorylates serine/threonine residues of specific substrates impeding 
cell cycle progression and promoting apoptosis, while its downregulation or 
inhibition is involved in tumorigenesis. Thus, PKCδ functions as a tumor 
suppressor. 
 
 
 20 
 
 
 
 
Figure 3: PKCδ structure 
The structure of PKCδ consists of two domains, a regulatory and a catalytic 
domain separated by a hinge region with the caspase-3 cleavage site.  
 
 
 
Protein Kinase C δ Signaling  
 
Upon activation, PKCδ phosphorylates serine/threonine residues in 
specific substrates. Synthetic peptides have shown a general phosphorylation 
motif  RXX(S/T)XRX, where X can be any amino acid123. Specifically, 
phosphorylation by PKCδ requires a hydrophobic amino acid at position +1 at the 
C-terminal of the phosphorylation site (Ser), glycine at position -1 and basic 
amino acids at positions -6, -5, -4, and -2123.  Ultimately, the optimal amino acid 
sequence for PKCδ phosphorylation is A(A/R)R(K/A)RKGSFF(Y/F)GG where the 
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serine adjacent to the phenylalanine is particularly important for PKCδ 
recognition.  PKCδ has several protein targets include p53, lamin B, and Rad9, 
that regulate several important cellular functions once phosphorylated 93,124. 
 
PKCδ Apoptosis Signaling 
 
As previously stated, PKCδ is activated by several stimuli (reactive oxygen 
species, ionizing radiation, anti-cancer agents, UV radiation, growth factors, 
cytokines) which initiate molecular mechanisms such as tyrosine phosphorylation 
and caspase-3 cleavage that initiate its pro-apoptotic activity125-128.  Apoptotic 
signaling is contingent on a predominance of pro-apoptotic signal. Regulation 
occurs through positive feedback in which PKCδ regulates caspase-3 increasing 
its own cleavage129-133.    
PKCδ apoptotic signaling begins with caspase-3 activation resulting in 
translocation of PKCδ catalytic fragment to the mitochondria where it facilitates 
cytochrome c release from the outer membrane of the mitochondria134. This 
occurs through a pathway in which the catalytic fragment of PKCδ induces turn-
over of Mcl-1, which is an inhibitor of Bax and Bak.  This releases inhibition on 
Bax causes release of cytochrome c and induction of apoptosis132,135. 
 
PKCδ and Cell Cycle Regulation 
 
In addition to PKCδs function in apoptosis, it also plays a role in cell cycle 
regulation in response to DNA damage. UV-induced cell cycle arrest is 
influenced by the active catalytic fragment of PKCδ, which induces a pronounced 
G2/M cell cycle arrest in murine embryonic fibroblasts (MEFs)
136. This cell cycle 
 22 
 
 
regulatory role occurs downstream of ATM/ATR kinases which are activated in 
response to different forms of DNA damage such as UV, ionizing radiation, and 
X-rays137. These findings have established PKCδ involvement in the DNA 
damage response because, if PKCδ is absent, a cell with damaged DNA would 
carry mutations through the G2/M cell cycle checkpoint while at the same time 
evading apoptosis.  
 
Loss of PKCδ in Skin Tumors 
 
The loss of tumor suppressors at either the genomic or protein level is 
necessary for development of human cancers. In chemically and UV-induced 
mouse skin tumors and in human SCCs, PKCδ protein levels are significantly 
reduced138-140. PKCδ is lost at the transcriptional level in SCC101. However, 
overexpression of PKCδ in SCC cell lines and mouse epidermis induces 
apoptosis and suppresses tumorigenicity138,139. Therefore, re-expressing PKCδ 
restores apoptotic functionality again representative of PKCδs tumor suppressing 
function101.  The mechanism of PKCδ downregulation in SCCs is unknown 
however it is likely that PKCδ is negatively regulated by active Ras which has 
been previously shown to down-regulated PKCδ protein and RNA in human 
keratinocytes101,138,140.  This is supported by findings that ras is active in ~60% of 
human SCCs  and >90%  of chemically induced mouse skin tumors141,142.  These 
mouse tumors with ras mutations were also deficient in PKCδ protein levels and 
activity suggesting an association between ras mutation and PKCδ loss139.  
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Summary  
 
Rationale and Hypothesis 
 
Bulky, helix-distorting DNA adducts, such as CPDs induced by UV 
radiation, are repaired by NER. Defects in NER complementation group genes 
give rise to familial cancer syndromes such as xeroderma pigmentosum, 
supporting the important tumor suppressive effects of NER. PKCδ expression is 
lost in squamous cell carcinomas where it functions as a tumor suppressor gene. 
PKCδ is activated in response to DNA damage downstream of ATM/ATR, and 
participates in inducing apoptosis and maintain the G2/M cell cycle checkpoint in 
response to UV radiation. Since cell cycle checkpoints are coupled to DNA 
damage repair pathways we hypothesis that cells deficient in PKCδ will have 
impaired ability to repair UV induced photolesions.  Furthermore, PKCδ loss will 
inhibit some aspects of the NER machinery.  
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CHAPTER TWO 
 
MATERIALS AND METHODS 
 
Cell Culture and UV Treatment 
 
Spontaneously immortalized MEFs from wild-type or PKCδ-/- mice 
(provided by Dr. Anning Lin University of Chicago) were cultured in Dulbecco’s 
modified Eagle’s medium (Invitrogen-11965-092) containing 10% fetal bovine 
serum and 1% penicillin/streptomyocin (Invitrogen).  UV irradiation was 
performed using a UV Panelite unit emitting UV wavelengths of approximately 
65% UVB, 34% UVA, and <1% UVC spectrums.  
 
Southwestern Blotting 
 
Cell lysates were collected by scrapping cells in 500µL DNA lysis buffer 
(10 mM Tris-HCl pH=7.8, 5mM EDTA, 0.3 M NaOAC, 1%SDS) and 5 µL 
proteinase K.  Samples were incubated overnight at 55⁰C.  Lysate DNA was 
purified from samples using the DNeasy Blood & Tissue Kit from Qiagen (69504).  
DNA concentration was determined using an Ultrospec 3000 UV/visible 
spectrophotometer from Pharmacia Biotech.  DNA samples were heat denatured 
at 100⁰C for 10 minutes.  A slot blot apparatus was used to vacuum transfer DNA 
samples onto  Hybond-N+ membrane.  DNA was crosslinked to the membrane 
using a UV stratalinker 1800 (Stratagene) at 70,000 Joules.  Overnight 
membrane blocking was carried out using denatured herring testes DNA 
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(Clontech-S0277) diluted in 1x TBS with 10% BSA.  Primary antibody used for 
immunostaining was Anti-CPD antibody (1:50; Kamiya Biomedical Company-TD-
M-2).  Goat anti-mouse IgG conjugated to Alexafluor-680 was used as a 
secondary antibody for detection with a LI-COR infrared scanning system (LI-
COR Biosciences).  
         
UV Absorbance/Transmittance 
 
UVA,UVB, and UVC absorbance of Dulbecco’s modified Eagle’s medium 
(Invitrogen-11965-092), Medium 154CF (Invitrogen-M154CF), Dulbecco’s 
Phosphate Buffered Saline 1X without calcium chloride and magnesium chloride 
(Invitrogen-14190-144), and Milli-Q water was determined using an Ultrospec 
3000 UV/Visible spectrophotometer (Pharmacia Biotech).  Percent transmittance 
was determined using the following calculation:  Absorbance= -log(percent 
transmittance/100). 
 
Immunofluorescence  
 
Cells, plated on sterilized coverslips in 6 well culture dishes, were fixed in 
a 1:1 acetone/methanol solution at -20⁰C for 10 minutes. A solution of 70 mM 
NaOH in 70% ethanol was added to fixed cells and incubated at room 
temperature for 2 minutes.  Cells were permeabilized in 0.1% Triton X-100. 
Primary antibodies against Thymine Dimers (CPD) (1:150, 1:200; Kamiya 
Biomedical Company-TD-M-2), XPA (1:50; Santa Cruz-sc-853), and XPC (1:50; 
Santa Cruz-sc-30156) were used along with secondary antibodies goat anti-
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rabbit IgG-Alexa Fluor-568, goat anti-rabbit IgG-Alexa Fluor-488, goat anti-
mouse IgG conjugated to Alexa Fluor-488.  Secondary antibody was followed by 
staining with 4',6-diamidino-2-phenylindole (DAPI).  Coverslips were mounted 
onto slides using Gelvatol. Images were generated using an Olympus Provis 
Microscope with Retiga 4000R 4.2 megapixel monochrome camera at 20x and 
40x magnification. 
 
Retroviral Constructs, Packaging, and Infection 
 
PKCδ-green fluorescent protein (GFP) constructs were provided by Dr. 
Mary E. Reyland (University of Colorado Health Sciences Center).  Viral 
constructs and retroviral supernatant were prepared by Edward LaGory and 
incubated at -80 ⁰C136.  For infection, polybrene (hexadimethrine bromide, sigma 
H-9268) was added to viral supernatant to a final concentration of 4 µg/ml.  
Retroviral Infection was performed in 6 well culture dishes by adding 2 mL of 
virus with polybrene to each well and incubated at 37⁰ C for 2 hours.  Virus was 
redistributed over the plate ever 15 minutes to ensure even distribution of virus 
over cultured cells. 
 
Immunoblotting 
 
Western Blot analysis was performed using 12.5% and 8.5% SDS gel for 
XPA and XPC staining respectively.  Cell lysates were collected by scraping cells 
in IP buffer (10 mM Tris-HCL, pH=7.5, 100 mM NaCl, 0.5% Triton X-100, and 
protease and phosphates inhibitors).  Lysates were briefly sonicated and 
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centrifuged at 14,000 rpm for 5 minutes to remove cellular debris.  Protein 
concentrations were determined using standard Bradford Reagent methodology.  
Primary Antibodies used for western analysis included XPA (1:50; Santa Cruz-
sc-853), XPC (1:50; Santa Cruz-sc-30156), and β-Actin (1:5000; ICN, 691001).  
Secondary antibodies used were  goat anti-rabbit IgG-Alexa Fluor-680, donkey 
anti-rabbit IgG-IRDye-800 and goat anti-mouse IgG  conjugated  to AlexaFluor-
680 for detection using a LI-COR infrared scanning system (LI-COR 
Biosciences). 
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CHAPTER THREE 
 
RESULTS 
 
Abstract 
PKCδ is a tumor suppressor frequently lost in chemically and UV-induced 
mouse and human skin tumors101,138,139.  This decline is due to downregulation of 
pro-apoptotic PKCδ at the transcriptional level resulting in increased survival of 
these skin tumors101,143.  Additionally, in response to UV-induced DNA damage, 
the catalytic fragment of PKCδ functions downstream of the ATM/ATR pathway 
and is essential for G2/M cell cycle checkpoint maintenance136.  Because cell 
cycle checkpoints are coupled to DNA damage repair pathways, we hypothesize 
that PKCδ may play a role in UVB-induced DNA damage repair. Our data 
demonstrates that PKCδ is essential for repair of CPDs following UVB-induced 
damage. 
 
PKCδ is Necessary for Efficient Repair of CPDs 
Cells exposed to UV radiation accrue damage that halts cell cycle 
progression.  Stalled cell cycle progression is essential for the repair of DNA 
damage and prevention of transmission of damage to daughter cells.  Because 
PKCδ is essential for maintaining UV-induced G2/M cell cycle arrest136, 
southwestern blotting was used to determine if Mouse embryo fibroblasts (MEFs) 
cells lacking PKCδ were capable of repairing UV-induced DNA adducts. 
29 
 
 
 
Southwestern blotting involves the transfer of pure DNA to a membrane which 
can then be visualized using immunostaining.  Cultured MEF cells were exposed 
to a 75 mJ/cm2 dose of UVB radiation.  After exposure, cells were given set 
amounts of time to repair their DNA (0 minutes, 10 minutes, 24 hours, 48 hours, 
and 72 hours).  After repair, cells were lysed, DNA was extracted and purified, 
and then DNA was transferred onto a membrane using a vacuum suction slot 
blot apparatus.  The membrane then underwent immunostaining with an antibody 
specific for CPDs.  From quantitation of band intensity, we then extrapolated 
degree of repair over time. At 10 minutes after UV, we observed comparable 
levels of CPDs between WT and PKCδ-/- cells. However, at 48 and 72 hours, we 
observed decreased amounts CPDs in WT MEFs when compared to PKCδ-/- 
cells (Figure 4A). Quantitation of this blot, supported these observations showing 
equivalent damage at 10 minutes and decreased CPD density after 48 hours in 
WT cells (Figure 4B).     
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A. 
 
B.       
 
 
Figure 4.  Analysis of UV-induced DNA Damage Repair 
 
Southwestern Blot of Wild-type and PKCδ-/- MEF DNA. A. 200 ng DNA sample 
with anti-thymine dimer antibody staining.  The reduction in band intensity 
signifies cellular repair B. Band intensity quantitation of 200 ng DNA quantity.  
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Media UV Absorption and Percent Transmission 
MEFs are routinely grown in DMEM medium with 10% FBS added.  
However, because of the presence of serum proteins and phenol red, this 
medium is likely to absorb significant amounts of UV radiation. With this in mind, 
we explored the possibility of administering UV to cells in different media that 
vary in absorption of UV wavelengths in order to decrease UV levels into a non-
apoptotic range.  We measured UV absorbance of wavelengths (200nm-400nm) 
of H2O, DPBS, DMEM with 10% FBS, and Media 154 (Figure 5A, 5B).  From 
these data, we were able to identify DPBS as an appropriate medium for 
dispensing UVB radiation because of its low UV absorbance/high percent 
transmittance, and thus accurate dosimetry.  This medium allowed us to use a 
UVB dose of 5 mJ/cm2 in which no apoptosis was observed.    
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A. 
 
B. 
 
Figure 5.  UV Absorption and Percent Transmission 
 
A. UV absorbance spectrophotometer measurements (200nm-400nm) of H2O, 
PBS-, DMEM, and Media 154.  B. Percent Transmittance measurements. 
Absorbance=-log(%transmittance/100). 
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Maximum Nuclear CPD Fluorescence After UVB Exposure   
UV radiation causes formation of CPDs immediately upon exposure.  
However, maximum antibody detection of photolesions in cells is not observed 
immediately after irradiation.  This observation is largely attributed to chromatin 
unwinding which provides space for NER proteins and may increase CPD 
antibody access. In order to observe repair of CPDs, we established a time point 
at which we could observe the greatest number of CPDs indicated by a maxima 
in CPD fluorescence intensity. We then performed immunofluorescene staining 
to visualize the kinetics of CPD detection in WT MEF cells. A low, non-apoptotic 
UVB dose of 5 mJ/cm2 was administered to cells plated in 6-well culture dishes in 
DPBS.  Cells were then returned to DMEM media and fixed using 
methanol/acetone at 10 min., 30 min., 1 hour, 2 hours, and 4 hours after UVB 
exposure. Using fluorescent imagining, we then observed DNA damage using 
levels of nuclear CPD fluorescence intensity (Figure 6A). We then quantitated the 
relative CPD fluorescence intensity per cell nuclei.  After quantitation, it was 
found that, on average, maxium CPD fluorescence was observed at 
approximately 1-2 hours after UV irradiation in WT cells (Figure 6B).  From these 
results, we chose a 2 hour fixation time point for subsequent experiments.  
 
 
 
 
 
 
 
 
34 
 
 
 
A. 
 Unirradiated       10                  30                  60                120               240   
        
          
igure 6. Maximum Nuclear CPD Fluorescence After UVB Exposure 
 
Immunofluorescence staining for CPDs at 10 minutes, 30 minutes, 1 hour, 2 
hours, and 4 hours after UV irradiation with 5 mJ/cm2 UVB in WT MEFs. 
Quantitation using Image J software indicates maximum detection of CPDs at 1 
hour after UV radiation is administered.  
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PKCδ is Required for Repair of UVB-Induced CPDs 
Using southwestern blotting, we showed that PKCδ-/- cells were defective 
in repairing UVB-induced damage. In order to confirm this observation, we 
performed quantitative immunofluorescence on WT and PKCδ-/- MEFs fixed 2 
and 48 hours after UVB-induced damage using a low dose (5 mJ/cm2) of UVB.  
These data, in figure 7A, show that irradiated WT cells were capable of repair of 
most CPD damage after 48 hours while PKCδ-/- cells had not repaired CPDs at 
48 hours. The maximum CPD damage at 2 hours was similar in both WT and 
PKCδ-/-. In addition to imaging, nuclear CPD fluorescence was quantified at 0, 2, 
and 48 hours after UVB treatment. Quantitation in figure 7B shows comparable 
levels of CPD fluorescence at 2 hours and  supports the observation that CPD 
levels are higher in PKCδ-/- cells at 48 hours after UVB treatment. In figure 7C, 
the 48 hour time point is displayed as an intensity distribution histogram and 
clearly shows two populations of cells that differ in their CPD repair capabilities.  
These results have proven to be both reproducible and highly significant 
(p<0.001). PKCδ-/- cells, however, did show a slight reduction in CPD 
fluorescence levels indicating that these cells are most likely capable of some 
level of CPD repair.  
 
 
 
 
 
36 
 
 
 
A. 
 
B.      
 
0
20
40
60
80
100
120
140
Control 2 48
A
v
e
ra
g
e
 C
P
D
 F
lu
o
re
s
c
e
n
c
e
 
P
e
r 
C
e
ll
 N
u
c
le
i
Hours After UV Treatment
WT MEF
PKCδ-/- MEF
P<0.001
37 
 
 
 
C. 
       
Figure 7.  Repair of UVB-Induced CPDs 
 
Immunofluorescene staining using anti-thymine dimer CPD antibody. A. 
Fluorescent intensities were similiar 2 hours after receiving 5 mJ/cm2 of UVB 
radiation. PKCδ-/- cells show an appreciably higher CPD fluorescence intensity 
at 48 hours indicating reduced CPD repair. B. Average fluorescence of WT 
(N=50) and PKCδ null (N=50) MEF at 0, 2, and 48 hours after UVB irradiation. C.  
Histogram of CPD fluorescence intensity distribution 48 hours after UV 
irradiation.  
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Re-expressing PKCδ in PKCδ-/- Cells Restores CPD Repair  
If PKCδ is solely responsible for the observed repair deficiency in the 
PKCδ-/- cells, then re-expressing PKCδ in PKCδ-/- cells should result in 
improved repair. In order to re-express PKCδ in PKCδ-/- cells, we used a 
retroviral system to tranduce full length, GFP-tagged PKCδ gene into cells 
lacking PKCδ. Once cells were transduced with PKCδ-GFP retrovirus, GFP 
immunofluorescence was performed to confirm transduction efficiency which was 
~70%. After exposure to 5 mJ/cm2 UVB, we observed that WT MEFs repaired 
nearly all damage and PKCδ-/- cells retained their CPDs (Figure 8). However, 
the PKCδ-/- cells transduced with PKCδ showed levels of nuclear CPD 
fluorescence intensity that were representative of both WT and PKCδ-/- repair 
capabilities (Figure 8A). Quantitation of nuclear CPD fluorescence indicated that 
PKCδ-/- cells transduced with PKCδ showed a high level of variability of the 
mean nuclear fluorescence intensity (Figure 8B). A CPD intensity distribution 
histogram at 48 hours after UV treatment shows that the large standard deviation 
observed in PKCδ transduced cells was due to two separate cell populations that 
were consistent with WT and PKCδ-/- cells (Figure 8C).  Additionally, these 
results were consistent with the roughly 70% transduction efficiency observed in 
PKCδ transduced cells (determined by GFP fluorescence).  These results 
indicate that lack of CPD repair in PKCδ-/- cells is not a secondary effect, but 
responsible for the observed defect in NER of CPDs in PKCδ-/- MEFs. 
Therefore, a cell that has lost PKCδ (which occurs in SCCs) can regain normal 
DNA damage repair capabilities if PKCδ expression is rescued.      
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C. 
 
 
Figure 8.  PKCδ Rescues CPD Repair Defect 
PKCδ rescues defective NER of CPDs in PKCδ-/- cells. A. Immunofluorescene 
staining using anti-thymine dimer CPD antibody. Cells exposed to 5 mJ/cm2 UVB 
have comparable CPD fluorescence intensity after 2 hours. However, 48 hours 
after UVB treatment, WT MEFs repair CPD damage, PKCδ-/- cells retain CPD a 
majority of CPD damage, and PKCδ transduced cells show cell populations that 
have both repaired and retained CPD damage. B. Average CPD fluorescence 
intensity per cell nuclei of WT (N=23), PKCδ-/- (N=17), and PKCδ-/- +PKCδ 
(N=19) MEFs at 0, 2, and 48 hours after UVB irradiation. C.  Histogram of CPD 
fluorescence intensity 48 hours after UVB treatment. 
 
 
 
 
 
0
1
2
3
4
5
6
7
8
9
3
0
4
0
5
0
6
0
7
0
8
0
9
0
1
0
0
1
1
0
1
2
0
1
3
0
1
4
0
1
5
0
1
6
0
1
7
0
1
8
0
1
9
0
2
0
0
2
1
0
2
2
0
2
3
0
2
4
0
2
5
0
N
u
m
b
e
r 
o
f 
C
e
ll
s
CPD Fluorescence Intensity
WT MEF
PKCδ-/- MEF
PKCδ-/- MEF 
+PKCδ
41 
 
 
 
PKCδ-/- Cells Have Decreased XPA and XPC Protein Levels  
The mechanism used to repair CPDs involves several essential proteins 
for identification and excision of the bulky lesions. However, not all of these 
proteins are essential for both GG-NER and TC-NER processes.  Additionally, 
nearly all NER genes are upregulated when cells are exposed to low dose of 
UVB74.  This upregulation leads to an increase in NER protein levels which can 
then be detected by western blot. In order to identify where in the NER process 
PKCδ is required, we performed western blots using whole cell lysates from cells 
that were exposed to low-dose UVB radiation. We then immunostained cells for 
DNA damage binding proteins XPC and XPA. XPC is critical for initial 
identification of DNA photolesions and is exclusive to GG-NER whereas XPA 
acts in both GG-NER and TC-NER and binds DNA damage in order to ensure 
excision of the lesion. For this experiment, we collected cell lysates at 0, 1, 3, 
and 6 hours after irradiation (Figure 9). We observed that NER proteins XPA and 
XPC were lower in non-irradiated PKCδ -/- cells and thus non-irradiated WT 
MEFs. Additionally, XPA increased after UVB treatment and was highest at 6 
hours in WT cells.  PKCδ-/- cells showed only a slight increase in XPA after 6 
hours (Figure 9A).  UVB treatment also caused an increase in XPC protein in WT 
cells 1 hour after treament.  This was in contrast to PKCδ-/- cells which showed 
an increase in XPC 6 hours after UVB treatment. 
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Figure 9: UVB Increases NER Protein Concentration Only In WT Cells 
 
Immunostaining for affect of UVB on NER Protein Levels. A. WT MEFs increase 
XPA and XPC protein levels in response to UVB treatment. B. Band Quantitation 
shows  differences in both endogenous XPA and XPC and UV induced protein 
increases of these NER proteins. 
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XPA is Not Recruited to the Nuclei of PKCδ-/- MEFs by UVB 
 
 In response to UVB radiation, cytoplasmic XPA is recruited to the 
damaged nucleus requiring a physical interaction with ATR56,144. In figure 10, 
immunofluorescence staining of XPA was used to observe UVB-induced 
increases in nuclear XPA levels in WT and PKCδ-/- cells. Fixed cells were 
stained at 6 hours after UVB treatment. The XPA stained WT MEF cells showed 
an increase in nuclear XPA staining after 6 hours whereas the PKCδ null cells 
experienced only a slight, non-significant increase in XPA levels (Figure 10A).  
Additionally, this difference in XPA fluorescence intensity at 6 hours was 
statistically significant (P<0.001) (Figure 10B).  These findings indicate that XPA 
nuclear localization is regulated by a pathway involving PKCδ.  
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A. 
 
B. 
 
Figure 10:  PKCδ is Crucial for UV-Induced Increase in Nuclear XPA 
 
Immunofluorescence staining for NER protein XPA after UV irradiation.  A. At 6 
hours after UV irradiation, WT cells show a higher nuclear XPA fluorescence 
intensity than PKCδ-/- cells.  B.  Average fluorescence intensity for XPA in WT and 
PKCδ-/- MEFs at 0 and 6 hours (P<0.001) after UV irradiation.  
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XPC is Not Recruited to the Nuclei of PKCδ-/- MEFs by UVB 
 
   XPC is part of a NER heterodimer complex that is the first protein in the 
GG-NER pathway. Beyond its DNA damage binding role, it also recruits 
subsequent NER proteins of the preincision complex to the site of damage39,41. 
Additionally, like XPA, the XPC gene is also shown to be induced by low levels of 
UVB74. In figure 11, immunofluorescence staining for XPC revealed that nuclear 
XPC protein increases significantly after 6 hours in WT cells. This UVB-induced 
increase was completely absent in PKCδ-/- cells (Figure 11A).  Additionally, 
quantiation of nuclear XPC fluorescence revealed significantly lower nuclear XPC 
fluorescence in PKCδ-/- MEFs compared to WT MEFs at 6 hours after UVB 
treatment (Figure 11B). Thus, one possible explanation for the observed low 
levels of nuclear XPA is the loss of recruitment signals from XPC. Reduced XPC 
could lead to impaired or complete loss of XPC mediated recruitment of 
succeeding NER proteins resulting in inhibition of normal functioning GG-NER.   
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A. 
 
B.  
 
Figure 11:  PKCδ is Crucial for UV-Induced Increase in Nuclear XPC 
 
Immunofluorescence staining for NER protein XPC after UV irradiation.  A. At 6 
hours after UV irradiation WT cells show a higher nuclear XPA fluorescence 
intensity than PKCδ-/- cells.  B.  Average fluorescence intensity for XPA in WT 
and PKCδ-/- MEFs at 0 and 6 hours (P<0.001) after UV irradiation. 
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CHAPTER FOUR 
 
DISCUSSION 
 
PKCδ is a Proapoptotic Tumor Suppressor 
 
PKCδ  has several well-characterized roles in cell growth, differentiation, 
cell cycle arrest, and apoptosis136,143. However, PKCδ is often lost in skin tumors 
potentially resulting in progression of cells with damaged DNA through cell cycle 
checkpoints and evasion of apoptosis101,139. Because cell cycle checkpoints 
ensure the fidelity of genetic material both by arresting cell cycle progression and 
facilitating DNA repair pathways, it is highly probable that proteins regulating cell 
cycle checkpoints such as PKCδ may also be involved in the DNA damage 
repair.  
PKCδ is known to associate with several DNA damage proteins 
associated with double-strand breaks including Rad9, DNA-dependent protein 
kinase (DNA-PKcs), and topoisomerase IIα115,145,146. The association of PKCδ 
with Rad9 is necessary for formation of the Rad9-Hus1-Rad1 complex, which is 
essential for regulation of checkpoint activation and the apoptotic response to 
DNA damage115,147.  Additionally, PKCδ catalytic fragment phosphorylates DNA-
PKcs inhibiting them from phosphorylating and activating downstream target 
p53146.  
PKCδ’s role in phosphorylating Rad9 and DNA-PKcs accentuate the 
importance of PKCδ in DNA damage-induced apoptosis.  Introduction of a 
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caspase-resistant mutant of PKCδ in keratinocytes inhibits activation of PKCδ-cat 
and results in partial prevention of cytochrome c release in mitochondria and loss 
of antiapoptotic Mcl-1148.  Additionally, the addition of ATM/ATR inhibitor caffeine 
to MEFs exposed to UV, results in progression of cells through cell cycle 
checkpoints and results in apoptosis in WT cells.  However, PKCδ-/- cells treated 
with caffeine and exposed to UV do not undergo apoptosis136.  Therefore, cells 
that either lack or inhibit proper function of PKCδ are predicted to be especially 
susceptible to mutagenesis due to failure of UVB DNA damage repair and 
resistance to apoptosis.  This is analogous to the tumor suppressor p53, which 
also functions in DNA damage response as the guardian of the genome, and in 
apoptosis as a cellular proofreader. 
 
PKCδ is Essential For Effective Repair of CPD 
Induction of DNA damage by UV light activates several cellular responses 
including NER and ATR-CHK1 signaling149.  Great progress has been made 
towards understanding the signaling along these pathways, but the details of how 
these responses are coordinated are still very poorly understood. We addressed 
the question of whether PKCδ was involved in DNA damage repair by performing 
southwestern blotting and immunofluorescence studies on fibroblasts isolated 
from WT and PKCδ-/- mice in order to visualize and quantitate DNA damage and 
NER protein nuclear localization. Using these two techniques, we were able to 
determine that PKCδ is necessary for efficient DNA damage repair of CPDs in 
response to UV radiation. Additionally, because bulky, DNA distorting lesions, 
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such as CPDs, are repaired via the NER mechanism, PKCδ signaling must affect 
some aspect of this mechanism. 
 
PKCδ Transduction Rescues NER Defect 
In order to provide conclusive evidence that the lack of PKCδ, and not an 
off-target effect, is responsible for the observed NER deficient phenotype in 
PKCδ null MEFs, we performed a retroviral transduction of PKCδ gene into 
PKCδ-/- cells. Because transduction of PKCδ rescued cellular ability to repair 
CPD damage, we were able to determine that loss of PKCδ alone is accountable 
for the observed deficiency in CPD repair in PKCδ-/- MEFs. As reported in the 
discussion of figure 8, we achieved a transduction efficiency of roughly 70%.  By 
determining how many cells fell within a particular range of CPD fluorescence 
intensity, we could ascertain that the number of cells that were capable of 
repairing CPD damage was consistent with our transduction efficiency. These 
results support our previous findings that PKCδ is essential for repair of CPDs.  
 
Several Possible Targets Exist for PKCδ  
DNA damage response affects a wide range of cellular processes.  
Central to DNA damage response are the PI3 kinase-like kinases ATM and ATR 
which are activated in response to double strand breaks and DNA bulky lesions 
respectively26,149.  ATM/ATR act by phosphorylating substrates that inhibit cell 
cycle progression and coordinate repair of lesions.  Downstream proteins of 
ATM/ATR include Chk1, Chk2, p53, and PKCδ136,149-153. The significance of 
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proper functioning ATM/ATR signaling is accentuated by the number of known 
debilitating disease associated with mutations in the kinases or mutations in 
other related protein components of DNA damage response. These diseases 
include xeroderma pigmentosum, ataxia telangiectasia, Seckel syndrome, and 
BRCA1 and BRCA2 in breast cancer154,155.  Recent discoveries concerning 
ATM/ATR signaling in skin cells have identified ATR as essential for translocation 
of NER protein XPA into the nucleus in response to UV induced adduct 
detection56,144.  Additionally, previous work from our lab has identified that the 
catalytic fragment of PKCδ also operates downstream of ATM/ATR in order to 
maintain G 2/M arrest in response to UV radiation
136. Because XPA and PKCδ 
are both downstream proteins of ATR signaling, we were interested in looking at 
whether PKCδ could also be affecting NER protein recruitment.  Using 
quantitative immunofluorescence, we were interested in determining where in the 
NER process PKCδ is involved. After observing a statistically significant 
difference in nuclear XPA levels at 6 hours post UV treatment, we were able to 
determine that PKCδ does affect localization of this protein as determined by 
immunofluorescence microscopy (Fig. 10).  However, nuclear XPA recruitment is 
also contingent on DNA damage binding protein XPC.  In the beginning stages of 
GG-NER XPC-hHR23B heterodimer identifies and binds the UV-induced adduct. 
XPC binding recruits proteins of the NER pre-incision complex to the site of the 
photolesion. This pre-incision complex includes XPA.  We also performed 
quantitative immunofluorescence staining on nuclear XPC.  Again, we saw 
nuclear accumulation of this XP protein in WT cells only. From these results, we 
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were able to determine that PKCδ is involved in nuclear localization/recruitment 
of the essential NER proteins XPA and XPC. However, it remains unclear as to 
whether the lack of nuclear XPA is due to PKCδ regulation of nuclear XPC levels. 
Western blot analysis of whole cell lysates also revealed differences in regulation 
of XPA and XPC between WT and PKCδ-/- MEFs.  These differences were 
observed in both endogenous and UV-induced protein levels. Experiments using 
low-dose UVB have shown increase in NER gene transcription. This observation 
has given rise to the thought that all NER proteins are regulated by a common 
signaling cascade in which PKCδ may be a part of.  
 It remains unknown as to the exact location within NER PKCδ is 
functioning. However, this research has identified an additional role for PKCδ in 
repair of UV-induced photoproducts, and is the first work to identify a role for 
PKCδ in the repair of DNA damage. Characterizing this additional role for PKCδ 
in NER will both enhance our knowledge of DNA damage molecular signaling 
and strengthen our appreciation for the complexity of cellular response to DNA 
damage.  Continued expansion of our knowledge of DNA damage repair 
signaling will undoubtedly present interesting opportunities for possible cancer 
prevention therapeutics in future research. 
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